MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/02676591211033946

Медицинская библиотека · Perfusion · 2021

Outcomes of extracorporeal life support for respiratory failure in children with primary immunodeficiencies.

Henry Brandon Michael, Benscoter Alexis L, de Oliveira Maria Helena Santos, Vikse Jens, Perry Tanya, Cooper David S

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Extracorporeal Membrane Oxygenation (ECMO) may serve as a life-saving rescue therapy in critically ill children with respiratory failure. While survival rates of ECMO in children with secondary immunodeficiency is considered relatively poor, survival rates in children with primary immunodeficiencies (PID) has yet to be thoroughly investigated.

DESIGN

Retrospective analysis of prospectively collected data from children (29 days-18 years old). PID patients were identified by using International Classification of Diseases (ICD) codes.

SETTING

Data were retrieved from Extracorporeal Life Support Organization Registry (1989-2018).

INTERVENTIONS: ECMO for a pulmonary support indication. The survival-to-discharge rate was calculated and factors influencing outcomes were compared between survivors and non-survivors.

MEASUREMENTS AND MAIN

RESULTS

A total of 73 eligible ECMO runs were included. The survival-to-discharge rate in pediatric PID patients was 45.2%. No differences were noted in survival based on type of immunodeficiency (p = 0.42) or decade of support (p = 0.98). There was no difference in the rate of pre-ECMO infection in survivors versus non-survivors (p = 0.69). The survival-to-discharge rate in patients with a culture positive infection during the ECMO run was 45.0% versus 45.3% in those with no infection (p = 0.98). In multivariate analysis, only cardiac complications (OR 5.09, 95% CI: 1.15-22.53), pulmonary complications (OR: 13.00, 95% CI: 1.20-141.25), and neurologic complications (OR: 9.86, 95% CI: 1.64-59.21) were independently associated with increased mortality.

CONCLUSION

Children with a PID who require extracorporeal life support due to respiratory failure have a reasonable chance of survival and should be considered candidates for ECMO. The presence of a pre-ECMO infection should not be considered an ECMO contraindication.

Для цитирования: Henry Brandon Michael, Benscoter Alexis L, de Oliveira Maria Helena Santos, Vikse Jens, Perry Tanya, Cooper David S. Outcomes of extracorporeal life support for respiratory failure in children with primary immunodeficiencies.. Perfusion. 2021. DOI: 10.1177/02676591211033946.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.